Mainz Biomed N.V. (QUCY) — Cash Flow-to-Debt Ratio
Mainz Biomed N.V. (QUCY) has a Cash Flow-to-Debt Ratio of -2.34x as of December 2025, meaning its operating cash flow of $-10.98 Million could theoretically repay -2% of its total liabilities ($4.69 Million) in one year. See Mainz Biomed N.V. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Mainz Biomed N.V. Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Mainz Biomed N.V. across 5 annual periods. Also explore QUCY net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Mainz Biomed N.V. (2021–2025)
Year-by-year debt coverage analysis for Mainz Biomed N.V.. For market capitalisation and broader financial context, see market cap of Mainz Biomed N.V..
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.34x | $-10.98 Million | $4.69 Million | ▲ +1.4% |
| 2024 | -2.38x | $-17.09 Million | $7.19 Million | ▼ -31.7% |
| 2023 | -1.80x | $-21.94 Million | $12.16 Million | ▲ +24.9% |
| 2022 | -2.40x | $-14.77 Million | $6.14 Million | ▼ -174.6% |
| 2021 | -0.88x | $-3.22 Million | $3.68 Million | — |